Tenascin-C, a biomarker of disease activity in early ankylosing spondylitis
Clinical Rheumatology Jan 12, 2018
Gupta L, et al. - Herein, researchers studied the serum and synovial fluid levels of tenascin-C (TNC) in ankylosing spondylitis (AS) and found that patients with AS had elevated serum TNC levels, which may serve as a marker of inflammation in early disease.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
